The Government of India, through the Ministry of External Affairs, has organized a significant visit for 30 health policymakers and experts representing 15 countries from the Global South. This initiative, held in collaboration with the Ministry of Health and the Indian Pharmacopoeia Commission (IPC), aims to foster deeper collaboration and exchange of expertise in the field of healthcare. The visit, taking place from August 19-22, 2024, reflects India’s commitment to strengthening ties with countries in the Global South and promoting shared health objectives.
The programme was inaugurated today in New Delhi by Union Minister of Health and Family Welfare, Jagat Prakash Nadda. In his opening remarks, Minister Nadda emphasized the importance of global cooperation in healthcare, particularly in the context of the ongoing challenges posed by pandemics, antimicrobial resistance, and the need for equitable access to medicines and vaccines. He highlighted India’s strides in healthcare innovation, quality control, and capacity building, and expressed hope that the visit would pave the way for mutually beneficial partnerships.
Focus on Indian Pharmacopoeia and Quality Control
A central focus of the visit is the Indian Pharmacopoeia, a vital compendium that sets standards for the quality of drugs in India. Policymakers and experts from the visiting nations will engage in discussions with their Indian counterparts on recognizing and adopting these standards in their own countries. This collaboration is expected to enhance drug quality, safety, and efficacy, which are crucial for ensuring public health.
In addition to these discussions, the visiting delegation will explore best practices in healthcare management, quality control, and capacity building. The Indian government aims to share its experiences and strategies, particularly in areas where it has achieved significant progress, such as the availability of affordable generic medicines through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
Site Visits to Agra and Hyderabad
The visit will also include field trips to Agra and Hyderabad, offering the delegation a firsthand look at India’s pharmaceutical and healthcare infrastructure. In Agra, they will visit a Janaushidhi Kendra, a government-run store that provides affordable generic medicines to the public. This visit will showcase how India is addressing the challenge of high drug prices and making healthcare more accessible to its population.
In Hyderabad, the delegation will tour a leading drugs and vaccines manufacturing unit, as well as a research laboratory. Hyderabad, often referred to as the “Pharmaceutical Capital of India,” is home to some of the world’s largest and most advanced pharmaceutical companies. These visits will provide the experts with insights into India’s capabilities in drug production, research, and development, particularly in the context of vaccines and biopharmaceuticals.
Strengthening South-South Cooperation
This visit is part of a broader effort by India to enhance South-South cooperation in healthcare. By sharing its expertise and experiences with other developing nations, India aims to contribute to global health equity and the achievement of Sustainable Development Goals (SDGs). The Ministry of External Affairs, through initiatives like this, is working to build a network of cooperation among countries in the Global South, with health as a key pillar of this collaboration.
As the visit progresses, it is expected that the interactions and exchanges will lead to concrete agreements and joint initiatives that will benefit the health sectors of the participating countries. The visit underscores India’s role as a leader in promoting health diplomacy and its commitment to building a healthier and more equitable world.
